Issue 7/2024
Yaneva, N., Vassilev, T.
Specialized Pediatric Hospital for Active Treatment “Prof. Dr. Ivan Mitev”, Department of Pediatrics, Medical University – Sofia
Abstratc:
Type 1 diabetes mellitus is a chronic disease with autoimmune destruction of pancreatic β-cells and lifelong need for treatment with exogenous insulin. The disease leads to a reduced quality of life, serious long-term complications, an average of 18 years of shortened life expectancy, and a significant burden on families and health systems. In recent decades technological advances have facilitated the development of automated insulin delivery systems aimed at improving metabolic control and quality of life for patients with type 1 diabetes. New technologies for monitoring and treating diabetes in children and adolescents are greatly improving the management of type 1 diabetes and the prevention of diabetes-related complications. Glucose-sensitive automated insulin delivery systems and closed-loop hybrid systems result in significantly improved glycemic control and reduced risk of hypoglycemia.
Key words: diabetes mellitus in children, treatment of diabetes mellitus